Crytococcus neoformans is a potentially life-threatening fungus that can cause serious infections, especially in individuals with weakened immune systems. The detection of this fungus at an early stage is crucial for effective treatment and management of the infection. One of the most reliable methods for identifying Crytococcus neoformans is through a Polymerase Chain Reaction (PCR) test.
The Crytococcus Neoformans Detection PCR Test is a highly sensitive and specific molecular diagnostic technique used to detect the presence of Crytococcus neoformans DNA in a patient's sample, which could be cerebrospinal fluid, blood, or tissue. This test employs PCR technology to amplify tiny amounts of DNA from the fungus, making it possible to identify an infection even when the fungal load is low.
DNA Labs UAE offers this advanced diagnostic test, providing a crucial tool for healthcare providers in the diagnosis and management of infections caused by Crytococcus neoformans. The test cost at DNA Labs UAE is set at 2220 AED. The facility ensures accurate and timely results, aiding in the prompt initiation of appropriate antifungal therapy for affected patients. Given the potential severity of infections caused by this pathogen, the availability of this test plays a significant role in improving patient outcomes through early detection and intervention.
The Coxsackie A Antibody Panel Test is a diagnostic tool used to detect the presence of antibodies against the Coxsackie A virus in the bloodstream. This type of virus is part of the enterovirus family and can cause a variety of illnesses, ranging from mild flu-like symptoms to more serious conditions such as myocarditis or pericarditis. The test is particularly useful in diagnosing cases where specific Coxsackie A virus-related symptoms are present, aiding healthcare providers in determining the appropriate course of treatment.
The test involves taking a blood sample from the patient, which is then analyzed in a laboratory setting to identify the presence and concentration of antibodies specific to the Coxsackie A virus. A positive result indicates that the individual has been exposed to the virus and has developed an immune response.
At DNA Labs UAE, the Coxsackie A Antibody Panel Test is available for individuals seeking to confirm exposure to the virus or diagnose related health conditions. The cost of the test is 2220 AED, reflecting the comprehensive analysis and reliable results provided by the laboratory's advanced diagnostic technologies and experienced professionals. This test is an important resource for patients and healthcare providers in the UAE, offering critical insights into viral infections and aiding in the management of associated health issues.
The 1,3-Beta-D-Glucan (BDG) Test is a diagnostic tool used to detect invasive fungal infections, including those caused by Candida, Aspergillus, and certain other types of fungi. This test measures the levels of 1,3-beta-D-glucan, a component of the cell walls of many fungi, in the blood. Elevated levels can indicate a fungal infection, making this test particularly useful in clinical settings for patients with symptoms of invasive fungal infections or for those at high risk, such as individuals with weakened immune systems.
In the United Arab Emirates, DNA Labs UAE offers the 1,3-Beta-D-Glucan Test at a cost of 2360 AED. DNA Labs UAE is known for its state-of-the-art facilities and commitment to providing accurate and reliable diagnostic services. The test is conducted in a controlled laboratory environment by experienced professionals, ensuring high-quality results. Patients or healthcare providers interested in utilizing this test can contact DNA Labs UAE for more information on scheduling and preparation requirements.
The Autogen Plus Panel Test, available at DNA Labs UAE, is a comprehensive genetic screening designed to provide individuals with insights into their genetic makeup. Priced at 2340 AED, this test covers a wide range of genetic markers to assess potential health risks, inherited conditions, and personalized responses to various medications. By analyzing your DNA, the Autogen Plus Panel Test can help in understanding your body's unique genetic predispositions, enabling you to make informed decisions about your health and lifestyle. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step towards personalized medicine, offering a detailed genetic profile that could be pivotal in preventive health strategies and tailored healthcare plans.
The Carcinoid Tumor Panel Test is a sophisticated diagnostic tool designed to detect and analyze specific markers associated with carcinoid tumors. Carcinoid tumors are a type of neuroendocrine tumor that usually grow slowly and can occur in various parts of the body, but most commonly in the gastrointestinal tract or the lungs. These tumors can produce and release hormones into the bloodstream, leading to a range of symptoms, including flushing, diarrhea, and wheezing, depending on the location and size of the tumor.
The test aims to provide comprehensive insights into the genetic makeup of the tumor, helping healthcare professionals in making accurate diagnoses, determining the prognosis, and tailoring personalized treatment plans for patients. By evaluating a panel of genes and biomarkers associated with carcinoid tumors, this test can also aid in identifying potential therapeutic targets, thereby optimizing treatment strategies.
Offered by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, the Carcinoid Tumor Panel Test is priced at 2340 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by a team of highly skilled professionals, ensuring that patients receive reliable and accurate test results. The cost of the test reflects the intricate technology and expertise required to analyze the genetic and molecular components of carcinoid tumors.
For patients suspected of having a carcinoid tumor or those undergoing treatment, this panel test represents a critical step towards understanding their condition better and managing it effectively.
Chimerism Pre-engraftment Donor and Recipient Test is a crucial diagnostic procedure performed to evaluate the success of bone marrow or stem cell transplants by analyzing the coexistence of donor and recipient cells in the patient's body. This test helps in monitoring and managing the patient's condition post-transplant, ensuring that the donor cells are properly engrafting and functioning within the recipient's body. It plays a significant role in predicting potential complications, such as graft-versus-host disease (GVHD), and in making informed decisions regarding the patient's treatment plan.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test offers a detailed insight into the chimeric status of an individual post-transplantation. By utilizing advanced genetic analysis techniques, DNA Labs UAE ensures accurate and reliable results, which are crucial for the ongoing care and management of transplant recipients.
The cost of the Chimerism Pre-engraftment Donor and Recipient Test at DNA Labs UAE is 2340 AED. This investment is vital for the meticulous monitoring required during the critical early stages post-transplant, enabling healthcare providers to optimize outcomes for their patients through personalized treatment adjustments based on the test results.
Hepatitis B Viral Drug Resistance and Genotyping Test is a critical diagnostic tool used in the management and treatment of Hepatitis B virus (HBV) infections. This test is designed to identify mutations in the HBV genome that can lead to resistance against antiviral drugs. By understanding the genetic makeup of the virus, healthcare providers can tailor treatment plans to effectively combat the infection and reduce the risk of drug resistance. The genotyping aspect of the test further helps in determining the specific strain of HBV, which can influence the choice of treatment and provide insights into the prognosis of the infection.
The test is available at DNA Labs UAE, a leading facility known for its advanced diagnostic services. The cost of the Hepatitis B Viral Drug Resistance and Genotyping Test is set at 2340 AED. This investment is crucial for individuals diagnosed with HBV, as it guides the selection of the most effective therapeutic strategies, potentially leading to better health outcomes and minimizing the risk of liver disease progression.
The "HLA DSA Donor Specific IgG Antibodies Class I and II Test" is a sophisticated diagnostic procedure available at DNA Labs UAE, designed to assess the presence of donor-specific antibodies (DSAs) in patients who have received organ transplants. This test specifically focuses on identifying IgG antibodies that target Class I and II Human Leukocyte Antigen (HLA) molecules. The presence of these antibodies can indicate an immune response against the transplanted organ, potentially leading to graft rejection. Therefore, this test is crucial for monitoring transplant compatibility and the long-term success of the transplantation.
The procedure involves a detailed analysis of the patient's blood sample to detect and quantify the DSAs, providing essential information for managing post-transplant care effectively. By identifying these antibodies early, clinicians can adjust immunosuppressive therapy accordingly to improve transplant outcomes and patient well-being.
The cost of the HLA DSA Donor Specific IgG Antibodies Class I and II Test at DNA Labs UAE is 2340 AED. Given the complexity and the critical nature of the information it provides, the test represents a valuable tool in the management of transplant patients, ensuring that personalized treatment plans can be developed and adjusted as necessary to protect the transplanted organ from immune-mediated damage.
The HLA T and B Cell Flow Cytometry Crossmatch Test is a sophisticated diagnostic procedure used to evaluate the compatibility between donor and recipient tissues prior to organ transplantation. This test is crucial in detecting the presence of antibodies in the recipient's blood that might react against the donor's human leukocyte antigens (HLA), which are markers found on the surface of cells. By specifically analyzing both T lymphocytes (T cells) and B lymphocytes (B cells), the test provides a comprehensive assessment of potential immune responses that could lead to transplant rejection.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test employs state-of-the-art flow cytometry technology. This technology allows for the precise and detailed analysis of multiple parameters of individual cells in a fluid as they pass by a laser, making it possible to detect even low levels of antibodies against donor HLA.
The cost of the HLA T and B Cell Flow Cytometry Crossmatch Test at DNA Labs UAE is 2340 AED. This price reflects the advanced technology and expertise required to perform such a detailed immune assessment, ensuring that patients receive the most accurate compatibility results before undergoing transplant procedures.
The HLA T and B Cell Lymphocyte Crossmatch Test is a crucial diagnostic procedure used to evaluate compatibility between organ donors and recipients, ensuring the success of transplants and minimizing the risk of rejection. This test specifically examines the interaction between the Human Leukocyte Antigen (HLA) molecules of the donor and the recipient's T and B lymphocytes, which are key components of the immune system. By identifying potential harmful reactions between the donor's organ and the recipient's immune cells, healthcare providers can make informed decisions about proceeding with transplantation.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test offers accurate and reliable results. The cost of the HLA T and B Cell Lymphocyte Crossmatch Test is set at 2000 AED, reflecting the sophisticated technology and expertise required to conduct this specialized analysis. By investing in this test, patients and medical teams can significantly enhance the likelihood of transplant success, paving the way for improved health outcomes.
